Showing results (241-250 of 335) with videos related to
Sort By:
Pageof 34
Cancer Chemotherapy and Pharmacology|May 13, 2010
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II doseKyle D Holen, Chandra P Belani, George Wilding, et al.Immunotherapy|September 7, 2018
Novel immunotherapy strategies for hepatobiliary cancersThomas T DeLeon, Yumei Zhou, Bolni M Nagalo, et al.Case Reports in Gastroenterology|December 7, 2016
Hepatoid Carcinoma of the Pancreas: Case Report, Next-Generation Tumor Profiling, and Literature ReviewJames M Chang, Nitin N Katariya, Dora M Lam-Himlin, et al.Physical Biology|December 1, 2012
Genomic analysis and selected molecular pathways in rare cancersStephen V Liu, Elizabeth Lenkiewicz, Lisa Evers, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreasR K Ramanathan, D Goldstein, R L Korn, et al.Journal of Clinical Pharmacology|January 15, 2011
Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignanciesHuali Wu, Ramesh K Ramanathan, Beth A Zamboni, et al.Pancreas|June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic CancerDavid Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patientsRamesh K Ramanathan, Douglas M Potter, Chandra P Belani, et al.The Oncologist|January 14, 2015
Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancerJosep Tabernero, E Gabriela Chiorean, Jeffrey R Infante, et al.International Journal of Nanomedicine|November 1, 2012
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patientsHuali Wu, Ramesh K Ramanathan, Beth A Zamboni, et al.Pageof 34